fda warning glp-1 november 2025 approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly February 17, 2026: Pennsylvania compounding

After 72 h, media was removed, and cells were washed thrice with DPBS

Many patients start at a lower dose and gradually adjust over time to help the body adapt and optimize results

The process for prior authorization can differ between insurance plans, but it usually means your healthcare provider will need to submit paperwork to your insurance plan confirming that you meet their eligibility requirements to take Ozempic

These authors concluded that the proportion of LBM relative to total body mass increased with semaglutide. Similarly, in the SURMOUNT-1 trial which studied tirzepatide, researchers found that participants treated with tirzepatide had a percent reduction in fat mass approximately 3 times greater than the reduction in lean mass, resulting in an overall improvement in body composition. More recently, a viewpoint in JAMA re-grounded the conversation: weight loss in persons with obesity primarily reduces body fat, but also decreases fat free mass (FFM)

A large retrospective study found a two-fold increased risk of anxiety and suicidal behavior and a three-fold increased risk of major depression among GLP-1RA users